Biogen (BIIB) Price to Sales (2009 - 2026)

Biogen has reported Price to Sales for 18 years, with the latest figure at 11.67 in Q2 2026.

• On a quarterly basis, Price to Sales rose 67.64% year-over-year to 11.67 in Q2 2026; TTM through Jun 2026 was 3.18, a 72.84% increase from a year earlier, with the FY2025 full-year figure at 2.61, up 13.36% from the prior year.
• Price to Sales was 11.67 for Q2 2026 at Biogen, up from 10.92 in the prior quarter.
• The five-year high for Price to Sales was 16.8 in Q2 2023, with the low at 6.96 in Q2 2025.
• Average Price to Sales over 5 years is 12.41, with a median of 11.93 recorded in 2026.
• The sharpest annual moves came in 2025 and 2026: Price to Sales slumped 49.19% in 2025, then soared 67.64% in 2026.
• Over 5 years, Price to Sales stood at 15.67 in 2022, then grew by 0.24% to 15.71 in 2023, then plunged by 42.19% to 9.08 in 2024, then grew by 24.79% to 11.33 in 2025, then climbed by 2.94% to 11.67 in 2026.
• The last three Price to Sales figures came in at 11.67 (Q2 2026), 10.92 (Q1 2026), and 11.33 (Q4 2025), per Business Quant data.